Pixuvri 29 mg
*Company:
Servier Laboratories Ireland LtdStatus:
No Recent UpdateLegal Category:
Product subject to restricted prescription (C)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Updated on 23 January 2023
File name
Pixuvri SmPC.pdf
Reasons for updating
- Document format updated
Legal category:Product subject to restricted prescription (C)
Updated on 30 November 2021
File name
Pixuvri 29mg PIL.pdf
Reasons for updating
- Improved presentation of PIL
Updated on 10 November 2021
File name
Pixuvri PIL.pdf
Reasons for updating
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
Updated on 16 November 2020
File name
Pixuvri SmPC.pdf
Reasons for updating
- Change to section 10 - Date of revision of the text
Legal category:Product subject to restricted prescription (C)
Updated on 16 November 2020
File name
Pixuvri PIL.pdf
Reasons for updating
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
Updated on 18 June 2019
File name
Pixuvri 29mg.pdf
Reasons for updating
- File format updated to PDF
Legal category:Product subject to restricted prescription (C)
Updated on 26 September 2018
File name
Pixuvri PIL.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
Updated on 02 July 2018
File name
Pixuvri PIL.pdf
Reasons for updating
- Change to section 6 - date of revision
Updated on 02 July 2018
File name
PIXUVRI.docx
Reasons for updating
- Change to section 10 - Date of revision of the text
Legal category:Product subject to restricted prescription (C)
Updated on 06 June 2018
File name
PIXUVRI.docx
Reasons for updating
- Change to section 10 - Date of revision of the text
Legal category:Product subject to restricted prescription (C)
Updated on 03 May 2017
Reasons for updating
- New SPC for new product
Legal category:Product subject to restricted prescription (C)
Updated on 03 May 2017
Reasons for updating
- Change to Section 4.8 – Undesirable effects - how to report a side effect
Legal category:Product subject to restricted prescription (C)
Free text change information supplied by the pharmaceutical company
Updated on 28 April 2017
File name
PIL_16289_177.pdf
Reasons for updating
- New PIL for new product
Updated on 28 April 2017
Reasons for updating
- Change to section 4 - how to report a side effect
Updated on 06 April 2017
Reasons for updating
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 9 - Date of first authorisation/renewal of the authorisation
Legal category:Product subject to restricted prescription (C)
Free text change information supplied by the pharmaceutical company
6.6. Reconstitution and dilution
9. Date of last renewal
Updated on 01 June 2016
Reasons for updating
- Change to date of revision
Updated on 25 May 2016
Reasons for updating
- Change to section 9 - Date of renewal of authorisation
Legal category:Product subject to restricted prescription (C)
Free text change information supplied by the pharmaceutical company
Updated on 29 April 2015
Reasons for updating
- New SPC for new product
Legal category:Product subject to restricted prescription (C)
Free text change information supplied by the pharmaceutical company
Updated on 20 April 2015
Reasons for updating
- New PIL for new product